RYAN ROGERS: Open Payments
NPI 1124325907 · OSAGE BEACH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 32 payments from 11 companies in 2025. Trend: 2023 $44 · 2024 $36 · 2025 $683
Food & beverage: $599Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $122 |
| ABBVIE INC. | 6 | $100 |
| Madrigal Pharmaceuticals | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| GENZYME CORPORATION | 2 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $50 |
| Gilead Sciences, Inc. | 2 | $30 |
| Ardelyx, Inc. | 2 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
Products named: TREMFYA, ENTYVIO, DUPIXENT, REZDIFFRA, XIFAXAN, SKYRIZI, IBSRELA, ZENPEP.
Industry payments across MO — which companies pay providers there.
